PECAM1 and hepatocellular carcinoma: On the other hand, the levels of β-NGF, CXCL1, CXCL9, CXCL12, IL-16, and PECAM-1 increased in patients with HCV and HCC and those of IFN-α and Prolactin only in HCC patients [39].